|
ATL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10590000046429E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.11500000133225E-08 |
| Normal-vs-Stage2 |
6.949900E-02 |
| Normal-vs-Stage3 |
8.962300E-04 |
| Normal-vs-Stage4 |
1.978050E-02 |
| Stage1-vs-Stage2 |
2.089600E-01 |
| Stage1-vs-Stage3 |
1.147360E-01 |
| Stage1-vs-Stage4 |
3.414000E-01 |
| Stage2-vs-Stage3 |
7.775400E-01 |
| Stage2-vs-Stage4 |
8.216600E-01 |
| Stage3-vs-Stage4 |
9.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51980000029361E-07 |
| Normal-vs-AfricanAmerican |
2.91050000000848E-06 |
| Normal-vs-Asian |
5.581800E-02 |
| Caucasian-vs-AfricanAmerican |
7.933400E-01 |
| Caucasian-vs-Asian |
5.846800E-01 |
| AfricanAmerican-vs-Asian |
5.479600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36370000239461E-08 |
| Normal-vs-Female |
2.279600E-03 |
| Male-vs-Female |
9.595100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.394330E-04 |
| Normal-vs-Extreme_Weight |
2.09160022635047E-10 |
| Normal-vs-Obese |
1.022970E-04 |
| Normal-vs-Extreme_Obese |
1.123980E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.372800E-01 |
| Normal_Weight-vs-Obese |
8.014600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.231800E-01 |
| Extreme_Weight-vs-Obese |
4.808000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.722470E-02 |
| Obese-vs-Extreme_Obese |
4.002000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.968000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.59529000000047E-05 |
| Normal-vs-Age(61-80Yrs) |
2.47379999818165E-08 |
| Normal-vs-Age(81-100Yrs) |
1.8438199999915E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.733410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.830300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.197900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.952100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.816000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.636200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.35050000019221E-07 |
| Normal-VS-Type2 PRCC |
3.3982000002819E-07 |
| Normal-VS-KIRP CIMP |
7.019400E-01 |
| Normal-VS-Unclassified PRCC |
1.187280E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.535600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.062200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.376000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.157000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.724800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.716000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.03760017139609E-10 |
| Normal-vs-N1 |
5.788800E-01 |
| Normal-vs-N2 |
6.007600E-02 |
| N0-vs-N1 |
4.996800E-03 |
| N0-vs-N2 |
2.863600E-01 |
| N1-vs-N2 |
4.503600E-01 |
|
|
